https://www.clinicaltrialsarena.com/uncategorized/newsspinifex-phase-ii-ema401-trial-meets-primary-endpoint/
Spinifex Phase II EMA401 trial meets primary endpoint - Clinical Trials Arena
Mar 20, 2023 - Spinifex Pharmaceuticals, an Australian pain drug development company, has reported that the Phase II trial of EMA401, for the treatment of postherpetic...
phase iiprimary endpointclinical trialsspinifexmeets
https://www.consultantlive.com/view/victorion-difference-inclisiran-achieves-primary-endpoint-of-ldl-c-reduction-versus-placebo
VICTORION-Difference: Inclisiran Achieves Primary Endpoint of LDL-C Reduction Versus Placebo
Patients with hypercholesterolemia on individualized maximally tolerated dose of statins achieved guideline-recommended LDL-C levels on inclisiran.
primary endpointdifferenceldlreductionversus
https://flcube.com/?p=38209
Eli Lilly's Jaypirca Achieves Primary Endpoint in Phase III BRUIN CLL-314 Trial - Insight, China's...
eli lillyprimary endpointphase iiibruincll
https://reachmd.com/news/darvadstrocel-misses-primary-endpoint-in-admire-cd-ii-trial/2486932/
Darvadstrocel Misses Primary Endpoint in ADMIRE CD II Trial - Be part of the knowledge - ReachMD
Key Takeaways Week-24 combined remission was similar between darvadstrocel and placebo, and the primary endpoint was not met. Key secondary efficacy measures,...
primary endpointpart ofthe knowledgemissesadmire
https://www.medicaldevice-network.com/news/newssphere-medicals-proxima-blood-analyser-meets-primary-endpoint/
Sphere Medical's Proxima blood analyser meets primary endpoint - Medical Device Network
Nov 25, 2011 - Sphere Medical's Proxima Generation 2 has met its primary endpoint in a multicentre clinical trial conducted at two UK hospitals, Queen Elizabeth Hospital...
primary endpointspheremedicalproximablood
https://ogkologos.com/phase-ii-lcmc3-study-of-neoadjuvant-atezolizumab-met-primary-endpoint-with-a-major-pathological-response-rate-of-20-in-resectable-stage-ib-iiib-nsclc/
Phase II LCMC3 Study of Neoadjuvant Atezolizumab Met Primary Endpoint with a Major Pathological...
phase iiprimary endpointstudymetmajor
https://markets.businessinsider.com/news/stocks/angiodynamics-meets-primary-endpoint-in-preserve-study-1034930536
AngioDynamics meets primary endpoint in PRESERVE study | Markets Insider
AngioDynamics (ANGO) announced the publication of results from the PRESERVE study in the journal European Urology. The study assessed the safety...
primary endpointmarkets insiderangiodynamicsmeetspreserve
https://www.panabee.com/news/biontech-adc-trastuzumab-pamirtecan-hits-primary-endpoint-in-phase-2-endometrial-cancer
BioNTech ADC Trastuzumab Pamirtecan Hits Primary Endpoint in Phase 2 Endometrial Cancer Trial |...
Phase 2 cohort for trastuzumab pamirtecan met primary endpoints with 48% confirmed objective response rate in centrally tested patients with recurrent...
primary endpointendometrial cancerbiontechadchits
https://www.fiercebiotech.com/biotech/sage-tweaks-primary-endpoint-for-zuranolone-depression-trial-leaving-key-durability
Sage tweaks primary endpoint for zuranolone depression trial, leaving key durability question...
Nov 2, 2021 - Sage Therapeutics has slightly tweaked the primary endpoint for a phase 3 trial of the Biogen-partnered depression drug zuranolone, a move analysts say is...
primary endpointsagetweakszuranolonedepression
https://health.economictimes.indiatimes.com/news/pharma/research-development/biontechs-cancer-drug-meets-primary-endpoint-in-phase-2-trial/112140756
COVID-19 Vaccine Maker: BioNTech's cancer drug meets primary endpoint in Phase 2 trial,...
COVID-19 Vaccine Maker: The trial met its primary endpoint, with data demonstrating a statistically significant improvement in the overall response rate in...
primary endpointcovidvaccinemakerbiontech
https://www.chemdiv.com/company/media/pharma-news/2026/roche-s-phase-iii-trial-of-fenebrutinib-in-rms-meets-primary-endpoint/
Roche's Phase III Trial of Fenebrutinib in RMS Meets Primary Endpoint
Roche reports its Phase III FENhance 1 trial for fenebrutinib in relapsing multiple sclerosis met its primary endpoint, reducing...
phase iii trialprimary endpointrochefenebrutinibrms
https://rss.globenewswire.com/fr/news-release/2025/02/03/3019385/0/en/GH-Research-Announces-Primary-Endpoint-Met-in-Phase-2b-Trial-with-GH001-in-TRD-Demonstrating-15-5-Point-Placebo-adjusted-MADRS-Reduction.html
GH Research Announces Primary Endpoint Met in Phase 2b
Primary endpoint met, GH001 led to an ultra-rapid anti-depressant effect with a significant placebo-adjusted MADRS reduction from baseline of -15.5 on Day...
primary endpointghresearchannouncesmet
https://www.news-medical.net/news/2009/03/11/46787.aspx
Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint
Jun 20, 2019 - Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients...
lupus nephritisprimary endpointstudymisses
https://medicaex.com/prnewswire/akesos-cadonilimab-pd-1-ctla-4-phase-iii-trial-meets-primary-endpoint-at-interim-analysis-demonstrating-strong-overall-survival-benefit-as-first-line-treatment-in-all-comer-patients-with-gastric/
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis...
Nov 13, 2023 - HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind,...
phase iii trialprimary endpointakesopdmeets
https://pharmaphorum.com/news/ema-backs-sv95c-digital-primary-endpoint-dmd-trials
EMA backs SV95C as digital primary endpoint for DMD trials | pharmaphorum
primary endpointemabacksdigitaldmd
https://www.tikr.com/pt/blog/grail-nasdaq-gral-stock-crater-47-after-cancer-drug-trial-fails-to-meet-primary-endpoint
Grail Stock Craters 47% After Cancer Drug Trial Fails To Meet Primary Endpoint | TIKR.com
Feb 24, 2026 - GRAIL stock plunges 47% after its massive cancer screening trial misses primary endpoint, raising questions about FDA approval and Medicare coverage prospects.
after cancerprimary endpointgrailstockcraters
https://www.ophthalmologymanagement.com/news/2025/aldeyra-therapeutics-achieves-primary-endpoint-in-phase-3-ded-chamber-trial-of-reproxalap/
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap |...
May 7, 2025 - Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through...
primary endpointtherapeuticsphasededchamber
https://ecancer.org/en/news/19536-wclc-2020-lcmc3-neoadjuvant-atezolizumab-safe-meets-primary-endpoint-of-pathologic-response-rate
WCLC 2020: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate...
Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated
primary endpointresponse ratewclcsafemeets
https://wiseek.ai/ticker/lpcn/lipocine-s-lead-ppd-candidate-fails-phase-3-primary-endpoint-raises-12m-via-highly-dilutive-atm-offering-000149315226021637/
Lipocine's Lead PPD Candidate Fails Phase 3 Primary Endpoint; Raises $12M via Highly Dilutive ATM...
May 7, 2026 - Lipocine Inc. reported a significant increase in net loss for Q1 2026 and announced that its lead postpartum depression (PPD) candidate, LPCN 1154.
primary endpointleadppdcandidatefails
https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2040763&key=blinatumomab
News for Medical Sales Reps: Phase 3 Study of BLINCYTO(R) (Blinatumomab) Met Primary Endpoint Of...
for medicalsales repsprimary endpointnewsphase
https://www.gsk.com/en-gb/media/press-releases/phase-iii-captain-study-of-trelegy-ellipta-in-patients-with-asthma-meets-primary-endpoint/
Phase III CAPTAIN study of Trelegy Ellipta in patients with asthma meets primary endpoint | GSK
Phase III CAPTAIN study of Trelegy Ellipta in patients with asthma meets primary endpoint
phase iiitrelegy elliptain patientsprimary endpointcaptain
https://www.talk.bio/2025/06/corcept-highlights-survival-benefit.html
Corcept Highlights Survival Benefit Despite ALS Trial's Missed Primary Endpoint
primary endpointhighlightssurvivalbenefitdespite
https://in.marketscreener.com/news/tozorakimab-met-primary-endpoint-in-both-oberon-and-titania-phase-iii-trials-in-patients-with-copd-ce7e51dbdf8bf122
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD...
Mar 27, 2026 - First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate...
primary endpointphase iiimetoberontitania
https://gabionline.net/es/biosimilares/investigacion/Phase-III-study-of-biosimilar-adalimumab-meets-primary-endpoint
Phase III study of biosimilar adalimumab meets primary endpoint
Biologicals major Amgen announced on 8 October 2014 the first late-stage data from its biosimilars programme. Primary efficacy analysis from a phas...
phase iiiprimary endpointstudybiosimilaradalimumab
https://igmpi.ac.in/news/clinical-research/phase-iii-thyroid-eye-disease-trial-of-innovent-fulfils-primary-endpoint
Phase III thyroid eye disease trial of Innovent fulfils primary endpoint
Phase III thyroid eye disease trial of Innovent fulfils primary endpoint
thyroid eye diseasephase iiiprimary endpointtrial
https://xagena.it/news/medicinenews_net_farmaci/68be68a4c8ce0d9d97e5259a649ce6a4.html
TRINOVA-1 trial: Trebananib in recurrent ovarian cancer study meets primary endpoint of...
Amgen has announced that the Phase 3 TRINOVA-1 trial evaluating Trebananib plus Paclitaxel versus placebo plus Paclitaxel in recurrent ovarian ...
recurrent ovarian cancerprimary endpointtrinovatrialstudy
https://www.ucviden.dk/en/publications/blinded-interpretation-of-the-primary-endpoint-results-from-the-s/
Blinded Interpretation of The Primary Endpoint Results From The Study: "An Individualised Treatment...
primary endpointresults frominterpretationstudytreatment
https://pressreleasehub.pa.media/article/imlifidase-successfully-meets-primary-endpoint-in-pivotal-us-phase-3-confides-trial-in-kidney-transplantation-55404.html
Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney...
primary endpointsuccessfullymeetspivotalus
https://www.takeda.com/newsroom/newsreleases/2019/phase-3-trial-of-ninlaro-ixazomib-as-first-line-maintenance-therapy-met-primary-endpoint-in-multiple-myeloma-patients-not-treated-with-stem-cell-transplantation/
Phase 3 Trial of NINLAROTM (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in...
Phase 3 Trial of NINLARO (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in Multiple Myeloma Patients not treated with Stem Cell...
first linemaintenance therapyprimary endpointphasetrial
https://www.merck.com/news/merck-announces-phase-3-keynote-355-trial-met-primary-endpoint-of-overall-survival-os-in-patients-with-metastatic-triple-negative-breast-cancer-whose-tumors-expressed-pd-l1-cps-%E2%89%A510/
Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival (OS) in Patients...
Apr 17, 2026 - KEYTRUDA Is the First Anti-PD-1 Therapy in Combination With Chemotherapy to Show Statistically Significant OS for This Patient Population Merck (NYSE: MRK),...
primary endpointmerckannouncesphasekeynote
https://fightec.org/astellas-announces-zolbetuximab-meets-primary-endpoint-in-phase-3-glow-trial-as-first-line-treatment-in-claudin-18-2-positive-her2-negative-locally-advanced-unresectable-or-metastatic-gastric-and-gas/
Astellas Announces Zolbetuximab Meets Primary Endpoint in Phase 3 GLOW Trial as First-Line...
primary endpointfirst lineannouncesmeetsphase
https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/clinical-spotlight/platinum-diversity-trial-primary-endpoint.html
PLATINUM Diversity Trial - Primary Endpoint - Boston Scientific
primary endpointboston scientificplatinumdiversitytrial
https://www.canceropole-est.org/la-recherche-au-sein-du-canceropole-est/annuaires/publications-scientifiques/detail/?id=691
Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology. -...
quality of lifehealth relatedprimary endpointclinical trialsco
https://www.biopharmaapac.com/news/26/7754/aroa-biosurgery-reports-positive-primary-endpoint-achievement-in-symphony-rct-for-diabetic-foot-ulcers.html
Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot...
Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers
aroa biosurgeryprimary endpointdiabetic footreportspositive
https://www.prnewswire.com/news-releases/taihos-tas-102-meets-primary-endpoint-of-improving-overall-survival-in-phase-iii-terra-study-in-asian-patients-with-refractory-metastatic-colorectal-cancer-300244624.html
Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in...
/PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. of Tokyo announced on April 1 results from its Phase III TERRA study on its oral combination anticancer drug...
primary endpointphase iiitasmeetsimproving
https://www.cis.lmu.de/schuetze/e/e/ep/epr/epri/eprim/eprima/OtHeR/eprimary_efficacy_endpoint.html
primary efficacy endpoint
primaryefficacyendpoint